Acumen Pharmaceuticals (ABOS) Current Leases (2022 - 2024)
Acumen Pharmaceuticals' (ABOS) quarterly Current Leases came in at $129000.0 in Q3 2024, up 6350.0% year-over-year from $2000.0 in Q4 2023, and up 3.2% quarter-over-quarter from $125000.0 in Q2 2024.
Powered by 
Analysis
Acumen Pharmaceuticals (ABOS) Current Leases (2022 - 2024) Analysis & Trends
Acumen Pharmaceuticals has disclosed Current Leases across 3 years of filings, most recently posting $129000.0 for Q3 2024.
- In Q3 2024, Current Leases rose 6350.0% year-over-year to $129000.0; the TTM figure through Sep 2024 stood at $129000.0 (up 6350.0% YoY), while the FY2023 annual figure was $756000.0, up 620.0% from the prior year.
- Current Leases came in at $129000.0 for Q3 2024 at Acumen Pharmaceuticals, up from $125000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $756000.0 in Q4 2023 to a low of $2000.0 in Q3 2023.
- Average Current Leases over 3 years is $158909.1, with a median of $125000.0 recorded in 2024.
- Year-over-year, Current Leases tumbled 98.5% in 2023 and jumped 6350.0% in 2024.
- Over 3 years, Current Leases stood at $105000.0 in 2022, then jumped by 620.0% to $756000.0 in 2023, then slumped by 82.94% to $129000.0 in 2024.
- Per Business Quant data, the three most recent Current Leases figures were $129000.0 in Q3 2024, $125000.0 in Q2 2024, and $121000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 12.38 Mn |
| 10 | Acumen Pharmaceuticals | 205.91 Mn | 205.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Mar 31, 2024 | 121,000.00 |
| Dec 31, 2023 | 756,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 133,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Mar 31, 2022 | 139,000.00 |